Patient Support Line 1-844-638-7222, Monday-Friday, 8:00 AM – 8:00 PM ET, excluding holidays.
What Is
PLUVICTO?
PLUVICTO is different
It's not chemotherapy. It's targeted treatment called radioligand therapy (RLT).
The FIRST and ONLY RLT for PSMA+ mCRPC
RLT is targeted radiation that is injected or infused. PLUVICTO is an RLT that targets a biomarker called PSMA.
Remember it in 3 steps
PLUVICTO is designed to find and attack PSMA+ cells. PSMA is found on many prostate cancer cells and also some healthy cells.
When PLUVICTO finds PSMA on the surface of a cell, it goes into the cell.
Once inside, PLUVICTO releases radiation, damaging or destroying the cell from within. It may also affect some nearby healthy cells.
![Over [25,000] men have already taken PLUVICTO. It could be your next step.](https://usim.beprod.us.pluvicto.com/sites/us_pluvicto_com/files/2025-11/2500_men_mobile.svg)
Download the PLUVICTO Comprehensive Brochure
Get all the information you need about treatment with PLUVICTO.
You’ll receive PLUVICTO at your closest PLUVICTO Treatment Center
mCRPC, metastatic castration-resistant prostate cancer; PSMA, prostate-specific membrane antigen; PSMA+, PSMA positive.